177 related articles for article (PubMed ID: 3668236)
1. PADS: a program to identify and diagnose prescription drug diversion in Indiana.
Indiana Med; 1987 Sep; 80(9):874-6. PubMed ID: 3668236
[No Abstract] [Full Text] [Related]
2. PADS approach to preventing prescription drug diversion.
Ambre JJ
NIDA Res Monogr; 1993; 131():141-4. PubMed ID: 8413524
[No Abstract] [Full Text] [Related]
3. PADS: a study of prescription drug diversion in Iowa.
Iowa Med; 1986 Aug; 76(8):352-5. PubMed ID: 3759372
[No Abstract] [Full Text] [Related]
4. Prescription drug diversion: "what Lola wants, Lola gets".
Thomison JB
J Tenn Med Assoc; 1989 Jan; 82(1):35-7. PubMed ID: 2927111
[No Abstract] [Full Text] [Related]
5. Arkansas prescription monitoring program implemented.
Robertson D
J Ark Med Soc; 2013 Jun; 109(13):278-9. PubMed ID: 23808093
[No Abstract] [Full Text] [Related]
6. The Illinois experience in achieving the medical/regulatory balance required to control prescription drug diversion.
Bishop MT; Vlasty RJ
NIDA Res Monogr; 1993; 131():159-75. PubMed ID: 8413527
[No Abstract] [Full Text] [Related]
7. An American Medical Association perspective on preventing prescription drug diversion.
Ambre JJ
NIDA Res Monogr; 1993; 131():224-7. PubMed ID: 8413533
[No Abstract] [Full Text] [Related]
8. New York State's Triplicate Prescription Program.
Eadie JL
NIDA Res Monogr; 1993; 131():176-93. PubMed ID: 8413528
[No Abstract] [Full Text] [Related]
9. New prescription drug abuse laws.
Howe CW
Mich Med; 1988 Aug; 87(8):463, 508. PubMed ID: 3193903
[No Abstract] [Full Text] [Related]
10. Update: Colorado Prescription Drug Abuse Coalition.
Colo Med; 1985 Jan; 82(1):13-4. PubMed ID: 3971676
[No Abstract] [Full Text] [Related]
11. Prescription drug use and abuse.
Meadows M
FDA Consum; 2001; 35(5):18-24. PubMed ID: 11697087
[No Abstract] [Full Text] [Related]
12. Prescription drug diversion.
Va Med Q; 1996; 123(2):132. PubMed ID: 8810894
[No Abstract] [Full Text] [Related]
13. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
[TBL] [Abstract][Full Text] [Related]
14. What you need to know: guidelines to medical practitioners for proper maintenance of drugs and dispensing records (including controlled drugs).
Yee SK
Singapore Med J; 1998 Nov; 39(11):520-2. PubMed ID: 10067392
[No Abstract] [Full Text] [Related]
15. [Comparative study of the consumption of drugs in the Mediterranean countries].
Ruíz Gijón J
An R Acad Nac Med (Madr); 1979; 96(2):243-67. PubMed ID: 532916
[No Abstract] [Full Text] [Related]
16. KASPER--a nursing perspective.
Hopkins DR
Ky Nurse; 2005; 53(3):19-20. PubMed ID: 16128114
[No Abstract] [Full Text] [Related]
17. Recognizing preventing and medication diversion.
Cole BE
Fam Pract Manag; 2001 Oct; 8(9):37-41. PubMed ID: 11685867
[No Abstract] [Full Text] [Related]
18. The Medicaid Prescription Drug Initiative.
Roslewicz TD
NIDA Res Monogr; 1993; 131():200-5. PubMed ID: 8413531
[No Abstract] [Full Text] [Related]
19. The MAPS program: stopping "doctor shoppers".
Wissel M
J Mich Dent Assoc; 2005 Dec; 87(12):38, 43. PubMed ID: 16463523
[No Abstract] [Full Text] [Related]
20. State program tracks Schedule II drugs.
Mirro MJ; Winkeljohn HA; Ragatz B
Indiana Med; 1993; 86(2):148-51. PubMed ID: 8463644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
